QS Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $34.4M | Buy |
877,216
+58,402
| +7% | +$2.27M | 0.41% | 32 |
|
|
2021
Q1 | $29.7M | Buy |
818,814
+21,111
| +3% | +$750K | 0.35% | 38 |
|
|
2020
Q4 | $29.4M | Sell |
797,703
-77,056
| -9% | -$2.83M | 0.35% | 37 |
|
|
2020
Q3 | $30.5M | Buy |
874,759
+540
| +0.1% | +$18.9K | 0.41% | 30 |
|
|
2020
Q2 | $27.1M | Sell |
874,219
-145,467
| -14% | -$4.94M | 0.38% | 33 |
|
|
2020
Q1 | $31.6M | Buy |
1,019,686
+67,531
| +7% | +$2.3M | 0.5% | 27 |
|
|
2019
Q4 | $35.4M | Buy |
952,155
+67,519
| +8% | +$2.4M | 0.35% | 33 |
|
|
2019
Q3 | $30.2M | Sell |
884,636
-35,048
| -4% | -$1.27M | 0.33% | 35 |
|
|
2019
Q2 | $37.8M | Buy |
919,684
+64,866
| +8% | +$2.58M | 0.41% | 27 |
|
|
2019
Q1 | $34.4M | Sell |
854,818
-87,873
| -9% | -$3.52M | 0.38% | 30 |
|
|
2018
Q4 | $39M | Sell |
942,691
-216,464
| -19% | -$8.99M | 0.5% | 22 |
|
|
2018
Q3 | $48.5M | Sell |
1,159,155
-27,736
| -2% | -$1.07M | 0.47% | 22 |
|
|
2018
Q2 | $40.9M | Sell |
1,186,891
-58,082
| -5% | -$1.98M | 0.4% | 29 |
|
|
2018
Q1 | $41.9M | Buy |
1,244,973
+417,473
| +50% | +$14.4M | 0.43% | 26 |
|
|
2017
Q4 | $28.4M | Buy |
827,500
+29,703
| +4% | +$1.01M | 0.27% | 51 |
|
|
2017
Q3 | $27M | Sell |
797,797
-78,408
| -9% | -$2.52M | 0.22% | 66 |
|
|
2017
Q2 | $27.9M | Sell |
876,205
-29,962
| -3% | -$945K | 0.24% | 62 |
|
|
2017
Q1 | $29.4M | Sell |
906,167
-299,125
| -25% | -$9.43M | 0.25% | 58 |
|
|
2016
Q4 | $37.1M | Sell |
1,205,292
-297,308
| -20% | -$9.08M | 0.3% | 57 |
|
|
2016
Q3 | $48.3M | Buy |
1,502,600
+52,876
| +4% | +$1.77M | 0.38% | 40 |
|
|
2016
Q2 | $48.4M | Sell |
1,449,724
-122,802
| -8% | -$3.92M | 0.41% | 38 |
|
|
2016
Q1 | $44.2M | Sell |
1,572,526
-402,088
| -20% | -$11.5M | 0.42% | 38 |
|
|
2015
Q4 | $60.5M | Buy |
1,974,614
+458,826
| +30% | +$14.4M | 0.58% | 22 |
|
|
2015
Q3 | $45.2M | Buy |
1,515,788
+627,945
| +71% | +$20.1M | 0.47% | 34 |
|
|
2015
Q2 | $28.2M | Sell |
887,843
-101,462
| -10% | -$3.31M | 0.35% | 55 |
|
|
2015
Q1 | $32.7M | Buy |
989,305
+37,685
| +4% | +$1.2M | 0.37% | 50 |
|
|
2014
Q4 | $28.1M | Buy |
951,620
+734,938
| +339% | +$21.1M | 0.32% | 65 |
|
|
2014
Q3 | $6.08M | Sell |
216,682
-29,504
| -12% | -$828K | 0.16% | 135 |
|
|
2014
Q2 | $6.93M | Sell |
246,186
-307,405
| -56% | -$8.76M | 0.19% | 133 |
|
|
2014
Q1 | $16.9M | Sell |
553,591
-49,644
| -8% | -$1.48M | 0.51% | 53 |
|
|
2013
Q4 | $17.5M | Buy |
603,235
+303,356
| +101% | +$8.83M | 0.67% | 37 |
|
|
2013
Q3 | $8.17M | Sell |
299,879
-391,487
| -57% | -$10.7M | 0.35% | 85 |
|
|
2013
Q2 | $18.5M | Buy |
+691,366
| New | +$19.1M | 0.65% | 37 |
|
Other funds holding PFE
QS Investors's PFE Position: Q2 2021 in Review
QS Investors increased its Pfizer (PFE) stake by 7.1% in Q2 2021, buying an estimated $2.27M and bringing the position to 877,216 shares worth $34.4M. The position accounts for 0.41% of the portfolio, ranked #32.
QS Investors first reported a position in PFE in Q2 2013 and has held it in 33 quarters since. The position peaked at $60.5M in Q4 2015. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- QS Investors held 877,216 shares of Pfizer worth $34.4M as of Q2 2021.
- QS Investors bought 58,402 Pfizer shares in Q2 2021, an estimated $2.27M.
- Pfizer made up 0.41% of QS Investors's portfolio in Q2 2021, its #32 holding.
- QS Investors first reported a position in Pfizer in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Pfizer position peaked at $60.5M in Q4 2015.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.